Status:
COMPLETED
Intracranial Hypertension and Optic Nerve Sheath Diameter
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cerebral Stroke
Cerebral Venous Thrombosis
Eligibility:
All Genders
2-16 years
Phase:
NA
Brief Summary
Intracranial hypertension (ICH) is a mortality risk factor in severe traumatic brain injury (TBI), in purulent meningitis, in hepatic encephalopathy and in Reye's syndrome. It is also a risk factor fo...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- For the 97 patients:
- children from 2 months to 16 years
- in the intensive care unit
- TBI : moderate (GCS between 9 and 12) to severe (GCS \<9), whatever the mechanism involved
- informed consent form signed by parents
- Non inclusion Criteria:
- obesity (BMI \> 97th percentile for the age)
- patient already under replacement therapy.
- patient taking AEDs
- patient with long-term systemic corticosteroid therapy
- history of neurological disease or learning difficulties
- no covered by a national health insurance
Exclusion
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT01796015
Start Date
April 1 2011
End Date
February 1 2017
Last Update
September 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Critical Care Unit, Hôpital Femme Mère Enfant ,Hospices Civils de Lyon
Bron, Auvergne-Rhône-Alpes, France, 69677
2
Pediatric Critical Care Unit, CHU La Tronche
Grenoble, France